Skip to main navigation

albireo_logo_nav.svg

  • About
    • Overview
    • Enterprise Team
    • Board of Directors
    • Partnering
    • Contact
  • Programs & Science
    • Bile Acids and IBAT Inhibition
    • Pipeline
    • Odevixibat
    • A3384
    • Elobixibat
  • Patients & Families
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • ALAGILLE SYNDROME
    • BILIARY ATRESIA
    • Chronic (Idiopathic) Constipation
    • ADULT LIVER DISEASES
    • Bile Acid Malabsorption (BAM)
    • Clinical Trials
    • Expanded Use
  • Media & Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Publications
    • 2020 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings

Committee Composition

Financials menu

  • Financials & Filings

Stock Information menu

  • Stock Information

governance menu

  • Corporate Governance
    • Senior Management
    • Board of Directors
    • Committee Composition
    • Contact the Board

Audit Committee Nominating and Governance Compensation Committee
Davey S. Scoon Audit Committee Compensation Committee
Anne Klibanski, M.D. Nominating and Governance
Stephanie Okey, M.S. Audit Committee
Michael Gutch, Ph.D. Audit Committee Compensation Committee
Roger A. Jeffs, Ph.D. Nominating and Governance Compensation Committee
David Chiswell, Ph.D. Nominating and Governance
= Chairperson = Member

Shareholder Tools

  • Email Alerts

    Email Alerts

  • RSS

    RSS

  • Print

    Print

 
albireo-white

© 2018 Albireo Pharma, Inc.

Contact |  Terms of Use  |  Privacy Policy      twitter